Investors



SEC Filings

Filing date Form Description Filing Group View
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
DEFM14A

Definitive proxy statement relating to merger or acquisition

Mergers & Acquisitions
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML

Data provided by Kaleidoscope.







© 2021 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MLR-0010 V16 03/2020

  • Ireland Address:
    Suite 206, Fitzwilliam Hall
    Fitzwilliam Place, Dublin 2, D02 T292
    Ireland
  • U.S. Address:
    900 Northbrook Drive, Suite 200
    Trevose, PA 19053
    United States

Phone: +1 610-254-9200
[email protected]

Privacy Statement
Compliance Program